Haffkine Institute gets Centre’s nod to manufacture Bharat Biotech’s Covaxin

- Covaxin is currently only manufactured by Bharat Biotech at three plants in Hyderabad, which have a combined annual capacity of 200 million, or 16-17 million per month. However, the production of the vaccine is far behind the current demand for the vaccine, which has an efficacy of 80.6%